Bruker Sets Fiscal 2026 EPS Outlook at $2.10-$2.15
The scientific instruments maker forecasts modest organic growth and margin expansion for the coming fiscal year.
Updated on Nov. 6, 2026 in Corporate Finance
Bruker set its fiscal 2026 non-GAAP earnings-per-share outlook at $2.10 to $2.15. The company forecasts reported revenue of $3.52 billion to $3.56 billion and 1% to 2% organic revenue growth.
Why it matters
The forecast signals that Bruker expects profitability to improve even as top-line growth stays modest. Its booking strength across several regions suggests demand in its instrument business may translate into future revenue.
Bruker forecasts $3.52 billion to $3.56 billion in reported revenue and 1% to 2% organic growth for fiscal 2026. Instrument shipment timing remains a variable that could shift quarterly results.
The players
Bruker
Bruker is a U.S.-listed scientific instruments and life sciences tools company that serves academic, government, and industrial research customers worldwide.
The details
Management expects fourth-quarter margin improvement, citing cost savings, favorable mix, earlier orders from China's academic and government markets, and some delayed semiconductor orders. Most semiconductor orders are expected to convert in fiscal 2027, with some in fiscal 2028.
Timeline
Fiscal 2026: the $2.10 to $2.15 non-GAAP EPS outlook applies.
Fourth quarter of fiscal 2026: management expects margin improvement.
Fiscal 2027: most delayed semiconductor orders are expected to convert.
Fiscal 2028: some semiconductor orders are expected to convert.
Corporate Finance Trajectory
Bruker's five consecutive quarters of book-to-bill ratios above one indicate order intake running ahead of revenue recognition. The fiscal 2026 outlook extends that pattern into forecasted margin gains and delayed semiconductor conversions expected in fiscal 2027 and 2028.
Investors tracking Bruker can use the $2.10 to $2.15 non-GAAP EPS range as a baseline for fiscal 2026 expectations. The guidance also highlights that semiconductor order conversion is expected to be gradual, spanning fiscal 2027 and 2028.
The takeaway
Guidance that pairs margin expansion with modest revenue growth points to cost discipline and order conversion as the key drivers to watch. Investors should track whether delayed semiconductor orders arrive on the timeline management has laid out.
Further reading
Explore more in Corporate Finance for context on how companies frame their annual guidance.
Source note: This article includes information reported by TokenPost.
